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Claire Raingevala , Olivier Calaa , Beatrice Briona, Marc Le Borgneb , Roderick Eliot Hubbardc,d and
Isabelle Krimma
aUniversite de Lyon, CNRS, Universite Claude Bernard Lyon 1, ENS Lyon, CRMN FRE 2034, Villeurbanne, France; bUniversite de Lyon, Universite
Claude Bernard Lyon 1, Faculte de Pharmacie – ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Sante Lyon-Est CNRS
UMS3453 – INSERM US7, Lyon, France; cYSBL, University of York, Heslington, York, UK; dVernalis (R&D) Ltd, Granta Park, Abington,
Cambridge, UK
ABSTRACT
WaterLOGSY is a sensitive ligand-observed NMR experiment for detection of interaction between a ligand
and a protein and is now well-established as a screening technique for fragment-based lead discovery.
Here we develop and assess a protocol to derive ligand epitope mapping from WaterLOGSY data and
demonstrate its general applicability in studies of fragment-sized ligands binding to six different proteins
(glycogen phosphorylase, protein peroxiredoxin 5, Bcl-xL, Mcl-1, HSP90, and human serum albumin). We
compare the WaterLOGSY results to those obtained from the more widely used saturation transfer differ-
ence experiments and to the 3D structures of the complexes when available. In addition, we evaluate the
impact of ligand labile protons on the WaterLOGSY data. Our results demonstrate that the WaterLOGSY
experiment can be used as an additional confirmation of the binding mode of a ligand to a protein.
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1. Introduction
Fragment-based lead discovery (FBLD)1,2 is maturing as an effect-
ive method for generating small molecules that modulate the
activity of biological molecules, usually proteins. The central idea
is to screen a small number (typically 1000 s) of low molecular
weight (usually less than 250Da) compounds against a protein
target of interest, mostly using a sensitive biophysical technique
that can detect binding with an affinity as weak as low mM (KD
for dissociation)2–4. Hit fragments are then optimised by either
growing or merging features of compounds to generate lead mol-
ecules. Such molecules can subsequently be used as tools to
probe the biology of a protein or be further optimised to give
clinical candidates such as the recently approved medicines,
vemurafenib, and venetoclax5,6. While it is relatively straightfor-
ward to find many (100 s of) fragments that bind for most pro-
teins7, it may be more difficult to characterise the molecular
interactions within the protein-fragment complexes when X-ray
crystallography is not successful. Yet the assessment of the ligand
binding mode is a critical information that provides important
guidance for the identification of suitable modification locations
in fragment optimisation.
NMR is a well-established method for screening fragment libra-
ries8. One of the most popular ligand-observed NMR experiments
is the saturation-transfer difference (STD) experiment9–12. The STD
spectrum displays the NMR peaks of a small molecule only if the
latter binds to the protein in the timescale of the experiment. In
addition, the size of the individual 1H STD signals reflects the
proximity of the corresponding proton to the protein. We have
previously shown that fragment binding mode can be
characterised using the so-called epitope mapping approach,
through the quantitative analysis of STD spectra13. The
WaterLOGSY experiment14,15 is another popular experiment for
the studies of molecular interactions16. WaterLOGSY is used for
the identification of protein ligands and the determination of pro-
tein-ligand binding constants17. The experiment provides some
key advantages. First, compound solubility can be checked which
prevents the selection of false positive hits due to compound
aggregation in the fragment screening experiments14,15. Also,
WaterLOGSY has been reported to be more sensitive compared to
STD18–20, and the development of dissolution dynamic nuclear
polarisation (D-DNP) WaterLOGSY may provide an even more sen-
sitive NMR method to detect protein-ligand interactions21. Finally,
WaterLOGSY is of particular interest for low proton density recep-
tors such as nucleic acids22 or for highly solvated proteins such as
amyloid fibers23.
The WaterLOGSY experiment involves several mechanisms for
the magnetisation transfer from the water to the protein and then
to the ligand11,14,15,24,25: (1) direct transfer from water molecules
immobilised in the protein binding site; (2) chemical exchange
between water and protein labile protons (amide, hydroxyl,
amino, etc.) (3) transfer from the water molecules found in the
protein surface via the protein-ligand complex. Thus, the solvent
accessibility of ligands bound to proteins can be assessed using
WaterLOGSY. The first demonstration of the use of the
WaterLOGSY experiment to measure bound-ligand solvent accessi-
bility was published in 2008 by the group of G€unther24,25, with
the quinone oxidoreductase 2 (NQO2) and two dehydrogenases
as protein targets. Since then, the group of Konrat published in
2017 a new approach to study the ligand solvent accessibility and
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proposed to analyse WaterLOGSY-based titration performed on a
perdeuterated protein sample26. The approach offers the advan-
tage of being applicable to low-molecular-weight proteins such as
bromodomains. However, a specific protein preparation is
required, which can be costly.
Here, we report an extensive study for the assessment of the
binding mode of small organic compounds bound to proteins,
through the WaterLOGSY experiment. For the first time, we investi-
gate the impact of ligand exchangeable protons on the
WaterLOGSY analysis. We compare, for six proteins with molecular
weights ranging from 22 to 180 kDa, the WaterLOGSY spectra to
the STD spectra recorded for each protein-ligand complex. Proteins
are the protein peroxiredoxin 5 (PRDX5), B-cell lymphoma-extra
large (Bcl-xL), Myeloid cell leukaemia 1 protein (Mcl-1), human
serum albumin (HSA), HSP90, and glycogen phosphorylase (GP).
2. Materials and methods
2.1. Biology
Glycogen phosphorylase from a rabbit muscle and human serum
albumin fatty acid free were purchased from Sigma (the referen-
ces are P1261 and A3782, respectively). Protein peroxiredoxin 5,
Bcl-xL, Mcl-1, and the N-terminal domain (9–236) of HSP-90 were
produced and purified at IBCP-Lyon “Bioengineering of proteins”
facility using Escherichia coli as previously described27,28. The fol-
lowing buffers were used: peroxiredoxin: 5 pH 7.4, NaCl 137mM,
KCl 2.8mM, Na2HPO4 10mM, KH2PO4 1.8mM, and 3mM DTT;
HSP90: Tris-HCl 20mM pH 7.5 NaCl 100mM and 1mM EDTA; Bcl-
xL: pH 7, Na2HPO4 25mM and 3mM DTT; Mcl-1: pH 8, Na2HPO4
50mM, NaCl 70mM, and 1mM EDTA.
2.2. NMR experiments
NMR samples for STD experiments consisted of 400mM fragment in
0.5% DMSO-d6 and 10% D2O (v/v) together with a protein concentra-
tion of 20mM for peroxiredoxin and HSP90, 10mM for Bcl-xL, 15mM
for Mcl-1, 2mM for glycogen phosphorylase, and 5mM for HSA.
Standard 1D, STD, and WaterLOGSY NMR spectra were
acquired at 20 C with an Agilent Inova 600MHz NMR spectrom-
eter, equipped with a room temperature 5mm triple-resonance
inverse probe with z-axis field gradient and a Bruker 600MHz
NMR spectrometer, equipped with a Z-gradient cryoprobe.
WaterLOGSY mixing time was 1.5 s, and additional experiments
were performed with 0.75 s and 0.25 s mixing time. Both STD and
WaterLOGSY spectra were recorded for each sample. WaterLOGSY
spectra in the absence of protein receptor were recorded with
400 mM compound. All the NMR experiments were performed at
293 K with excitation sculpting to suppress peaks from water. 1 D
and STD experiments were performed using identical experimen-
tal conditions (spin lock, interscan delays), and parameters for the
STD experiments (saturation frequency and saturation time) were
identical for all samples. Selective saturation of the protein NMR
spectrum was achieved with the decoupler offset 2500Hz upfield
from the carrier frequency, and non-saturation control was per-
formed at 15,000Hz downfield. Saturation time was set to 2 s for
all experiments. The STD factors were calculated according to the
following equation: R¼(ISTD/I1D)100) were ISTD and I1D are the
intensity of proton resonances of the STD and the 1D proton
spectra, respectively. STD spectra were normalised by setting the
largest observed signal to 100% of the equivalent 1D signal.
2.3. Molecular docking
All docking computations were performed with AutoDock4.2.329.
Two-hundred independent runs were conducted for each frag-
ment using the Genetic Algorithm with standard settings.
Structure PDB entry 3MNG containing PRDX5 in interaction with
DTT and 1AO6 containing HSA were used as the 3D template for
the docking. Protein and fragment structures were prepared with
AutoDockTools (ADT). The standard AutoDock-potential scoring
function was used as previously explained27.
3. Results and discussion
3.1. Quantitative comparison of WaterLOGSY signals of ligands
free and bound to the protein receptor
In the WaterLOGSY experiment, the molecules that interact with
water via water-ligand-protein or protein-ligand complexes exhibit
a negative NOE with water (positive WaterLOGSY signal), while
the molecules that do not bind the protein have weak and posi-
tive intermolecular NOEs with water (negative WaterLOGSY signal).
Although the overall change of sign is dependent on the ligand/
protein ratio, binding and non-binding ligands can be discrimi-
nated in a WaterLOGSY spectrum, as they display opposite signs
for their corresponding peaks14,15.
In the so-called SALMON effect, the sign of the WaterLOGSY
peaks was observed to remain negative (as for free ligands) for
solvent-exposed protons of the 5-(aziridin-1-yl)-2,4-dinitrobenza-
mide bound to NQO2, compared to the peaks from buried pro-
tons of the ligand. For cases where no proton displayed negative
WaterLOGSY peaks, the intensities of individual protons were com-
pared with those in the 1D spectrum24,25.
Here we propose to compare the WaterLOGSY intensities of
the bound ligand to the WaterLOGSY intensities of the free com-
pound, to highlight changes in intensities upon protein binding,
as the WaterLOGSY intensities of protons in organic compounds
do not necessarily reflect the intensities observed in normal 1D
spectra. This is due to the WaterLOGSY mechanism that involves
magnetisation transfer from bulk water. Therefore, we propose
the following protocol to quantitatively evaluate the WaterLOGSY
signals of the protons of a compound bound to its receptor. We
define a WLOGSY factor calculated using magnitudes of
WaterLOGSY signals as: WLOGSY factor¼j(IWLOGSYþ) – (IWLOGSY)j/
j(IWLOGSY)j, with IWLOGSYþ and IWLOGSY the WaterLOGSY
peak intensities in the presence and absence of the protein.
The values are then normalised with the highest value for the
WLOGSY factor of the corresponding proton set to 100%. The
smallest WLOGSY factor value corresponds to the most solvent-
exposed proton. The different possible scenarios are illustrated
schematically in Figure 1, where theoretical WaterLOGSY spectra
are displayed for a compound containing three protons (Figure
1(A)). For clarity, the intensities are normalised for the spectra in
the presence or absence of the protein, using the proton H1
(exhibiting the strongest WaterLOGSY intensity in the absence of
the protein) as a reference. In Figure 1(B), the spectra are phased
to allow superimposition. In this way, the comparison of the two
WaterLOGSY spectra is similar to the comparison of STD and
STDoff spectra, with the WaterLOGSY bound spectrum corre-
sponding to the STD spectrum and the WaterLOGSY free spectrum
corresponding to the STDoff spectrum30. In cases 1–4, the proton
H1 displays a change of WaterLOGSY signal intensity between the
free and bound WaterLOGSY spectra.
In case 1A, the WaterLOGSY signals display opposite signs
upon binding to the protein. However, when the WaterLOGSY
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spectrum of the free compound is phased to allow superimpos-
ition with the WaterLOGSY spectrum of the bound compound, the
WaterLOGSY intensities are similar for each of the three protons
(case 1). As a consequence, the WLOGSY factors are 100% for the
three protons, indicating that the binding has no impact on the
WaterLOGSY intensities. This arises either because the ligand binds
to the protein in multiple orientations in one or more binding
sites, or because the ligand is fully buried in the protein, or
because no specific proton is solvent-exposed in the correspond-
ing binding mode (see Figure 2(A)). In case 2, the WaterLOGSY
signals exhibit opposite signs upon binding to the protein but the
relative WaterLOGSY intensity is weaker for proton H3 (case 2, see
Figure 2(B) and Figure 3). The WLOGSY factor is 75% for proton
H3, indicating that proton H3 is solvent-exposed in the complex
structure. In case 3, the WaterLOGSY signal of proton H3 still dis-
plays a negative sign, while protons H1 and H2 display positive
WaterLOGSY signals upon binding to the protein (case 3). This
case is experimentally observed for compounds bound to low
molecular weight receptors (25–30 kDa), due to the reduced spin
diffusion (see Figure 4). The WaterLOGSY mechanisms involving
the cross-relaxation rates between the proton and proximal pro-
tein protons and the cross-relaxation rates between the proton
and water molecules are in competition, and the relative influence
of these mechanisms depends on the receptor molecule weight.
In case 3, the WLOGSY factor is 25% for proton H3, indicating that
proton H3 is solvent-exposed in the complex structure. Finally, in
case 4, the WaterLOGSY signals of protons H1, H2, and H3 still dis-
play a negative sign, but proton H3 exhibits a weaker
WaterLOGSY signal intensity upon protein binding. This implies
that proton H3 is less solvent-exposed than protons H1 and H2.
Below, each of these 4 cases is illustrated with experiments on six
different protein receptors.
3.2. Structural information from WaterLOGSY spectra
We first demonstrate that WaterLOGSY is sensitive to the orienta-
tion of the bound ligand and can discriminate specific (one
defined orientation, case 2) from non-specific binding (multiple
orientations, case 1). Figure 2 shows the WaterLOGSY spectra of
compound 1 (4-methylcatechol) free and bound to PRDX5
(36 kDa) and HSA. As highlighted in Figure 2(B), the proton H1 of
compound 1 has a WLOGSY factor of 75%, consistent with its
solvent exposure in the crystallographic complex structure and
previously reported STD-NMR data27. By contrast, as can be seen
in Figure 2(A), all the protons of compound 1 bound to HSA
exhibit WLOGSY factors of 100%. This shows that compound 1
binds HSA without any preferred orientation, in agreement with
the propensity of the protein to bind a large diversity of com-
pounds nonspecifically31.
To further demonstrate that WaterLOGSY generates structural
information, we report WaterLOGSY spectra for four other proteins,
Mcl-1, and GP (Figure 3), the N-terminus of HSP90 (Figure 4), and
Bcl-xL (Figure 5). Mcl-1 and Bcl-xL, anti-apoptotic Bcl-2 family mem-
bers frequently upregulated in cancer, are representatives of pro-
teins involved in protein-protein interactions. GP is a representative
of allosteric enzymes and has been chosen because of its high
molecular weight (180 kDa). HSP90, a widely studied target in
oncology and the subject of multiple fragment and structure-based
discovery campaigns32, was selected for its low molecular weight
(25 kDa) and for the well characterised X-ray structures of frag-
ments binding to the protein.
Examples for Mcl-1 and GP binding to compound 2 5-chloro-1H-
indole-2-carboxylic acid and 3 2,4-(1H,3H)-quinazolinedione,
respectively, are shown in Figure 3. In both cases, the WaterLOGSY
spectra identify solvent-exposed protons of the bound ligands, in
Figure 1. Schematic representation of WaterLOGSY-based characterisation of protein ligands. Four different cases are illustrated for a compound exhibiting three pro-
tons H1, H2, and H3 (see the text). (A) Theoretical WaterLOGSY spectra, in the absence (blue) and in the presence (red) of the protein receptor, are displayed. To facili-
tate the comparison of the relative intensities, the WaterLOGSY ones are normalised, using the peak with the strongest WaterLOGSY intensity in the absence of
protein as the reference peak (here H1). (B) Theoretical WaterLOGSY spectra, in the absence (blue) and in the presence (red) or the protein receptor, with the
WaterLOGSY spectrum of the free compound, phased to allow the superimposition with the WaterLOGSY spectrum of the bound compound. The WaterLOGSY factors
are calculated using hypothetical intensities, using the equation j(IWLOGSYþ) – (IWLOGSY)j/(IWLOGSY)j and reported for the three protons H1, H2, and H3. The values are
then normalised, similarly to the calculation of STD factors, with the highest value set to 100%. Calculations for the protons (H1, H2 and H3) are detailed here. Case 1
((IWLOGSYþ)¼ (IWLOGSY) for H1, H2 and H3): WLOGSYH1¼WLOGSYH2¼WLOGSYH3¼ 2 and are all normalised to 100%. Case 2 ((IWLOGSYþ)¼ (IWLOGSY) for H1 and
H2; (IWLOGSYþ)¼ 1/2 (IWLOGSY) for H3): WLOGSYH1¼WLOGSYH2¼ 2 and WLOGSYH3¼ 1.5, corresponding to 100%, 100%, and 75%, respectively. Case 3
((IWLOGSYþ)¼ (IWLOGSY) for H1 and H2; (IWLOGSYþ)¼ 1/2 (IWLOGSY) for H3): WLOGSYH1¼WLOGSYH2¼ 2 and WLOGSYH3¼ 0.5, corresponding to 100%, 100%, and
25%, respectively. Case 4 ((IWLOGSYþ)¼ (IWLOGSY) for H1 and H2; (IWLOGSYþ)¼ 1/2 (IWLOGSY) for H3): WLOGSYH1¼WLOGSYH2¼ 0 and WLOGSYH3¼ 0.5, corresponding
to 0%, 0%, and 100%, respectively.
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complete agreement with the STD-based epitope mapping (Figure
3). Those are typical examples of case 2 displayed in Figure 1.
The theoretical case 3 shown in Figure 1 may be observed for
protein targets with low molecular weights (below 25 kDa). Due to
the low spin diffusion, a solvent-exposed proton can exhibit a
negative WaterLOGSY peak. This case is illustrated for compound
4 (N,N-diethylvanillamide) bound to the N-terminal domain of
HSP90 (Figure 4). The WaterLOGSY spectrum suggests that the
proton H1 of compound 4 is solvent-exposed upon binding to
HSP90 (WLOGSY factor is 10%). This observation is consistent with
the STD data and the published X-ray structure (Figure 4)32.
Finally, case 4 is exemplified with Bcl-xL (22 kDa) (Figure 5). If
the ligand/protein ratio is large, in particular for low molecular
weight receptors, the WaterLOGSY spectrum of the bound ligand
may maintain a negative sign for all protons, as shown in
Figure 1, case 4. This is not problematic for the analysis of the lig-
and orientation, as illustrated in Figure 5 where the WaterLOGSY
spectra of compound 5 (40-fluoro-[1,10-biphenyl]-4-carboxylic acid)
free and bound to Bcl-xL are compared. While both WaterLOGSY
spectra display the same sign, there are differences in the
WaterLOGSY intensities. In this case, solvent-exposed protons dis-
play unchanged WaterLOGSY intensities (the corresponding pro-
tons are not influenced by the binding), while buried protons
exhibit weak intensities. For compound 5 bound to Bcl-xL, STD
spectra indicate that protons H1 are solvent-exposed, while pro-
tons H3 are buried in the protein surface. In agreement with the
STD data, the relative WaterLOGSY signal intensity of protons H1
is not modified, suggesting that protons H1 are solvent-exposed.
By contrast, the WaterLOGSY signal intensity of protons H3 is
weaker upon binding, showing that protons H3 are buried in the
protein-ligand complex. Those observations are in agreement with
the NMR structures of the fragment-protein complex33.
Those six different examples show that the WaterLOGSY experi-
ment can provide information on ligand binding mode for vari-
ously sized proteins, and demonstrates that it is not necessary to
adjust (increase) the protein concentration in order to obtain posi-
tive WaterLOGSY signals (a change in the WaterLOGSY sign upon
binding), since comparison of WaterLOGSY intensities for the pro-
tons of free and bound ligands provides the required information.
3.3. Influence of ligand exchangeable protons on the
WaterLOGSY experiment
As described by Dalvit, the WaterLOGSY intensity depends, both
for the free and bound ligands, on the presence of ligand
Figure 2. WaterLOGSY spectra for a compound bound to a protein target (A) without any defined orientation or (B) through a defined orientation (cases 1 and 2): (A)
Compound 1 bound to HSA (KD > 1mM) B) Compound 1 bound to PRDX5 (KD¼330lM). The STD spectrum is shown in green, with the STDoff spectrum (1D) super-
imposed in black. The WaterLOGSY spectrum in the absence of the protein is shown in blue, the WaterLOGSY spectrum in the presence of the protein is shown in
red. The solvent-exposed proton H1 identified using WaterLOGSY and STD experiments is labelled. The corresponding WaterLOGSY and STD factors are indicated. The
X-ray structure is shown for compound 1 bound to PRDX5 (4K7N) and compound 1 docked in HSA. All docking computations were performed with AutoDock4.2.329.
Figure 3. WaterLOGSY detects that fragments bind the protein target through a
defined orientation and identifies solvent-exposed ligand protons: case 2. (A)
Compound 2 bound to Mcl-1 (KD not determined) (B) Compound 3 bound to GP
(KD >1mM). The STD spectrum is shown in green, with the STDoff spectrum (1D)
superimposed in black. The WaterLOGSY spectrum in the absence of the protein
is shown in blue, the WaterLOGSY spectrum in the presence of the protein is
shown in red. The solvent-exposed proton H1 identified using WaterLOGSY and
STD experiments is labelled. The corresponding WaterLOGSY and STD factors
are indicated.
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exchangeable protons14,15. It is acknowledged that labile protons
display positive exchange peaks in WaterLOGSY spectra even in
the absence of the protein. This mechanism might, therefore,
affect the WaterLOGSY intensities of the protons located nearby
labile protons (distance <5Å), due to the 1/R6 dependence of the
NOE transfer. A proton located near a labile proton (such as OH
and NH) should experience a large negative NOE. It might, there-
fore, be difficult to identify solvent-exposed ligand protons
(through small WLOGSY factors) when the latter are nearby labile
protons. This will depend on the balance between the different
effects. The sensitivity of the WaterLOGSY experiment is mainly
due to an efficient magnetisation transfer via spin diffusion
through the protein complex. Consequently, the WaterLOGSY sig-
nal is larger for proteins with large correlation times. It is for this
reason that WaterLOGSY experiments are typically achieved with
long mixing times ranging from 1 s to 2 s. The signal-to-noise ratio
rapidly decreases when shorter mixing times are used. By contrast,
the magnetisation transfer involving labile protons of the ligand
remains highly efficient at shorter mixing times.
To study the influence of exchangeable protons, WaterLOGSY
experiments were performed with mixing times of 1.5, 0.75, and
0.25 s for 20 protein-fragment complexes. We have compared the
relative intensities of the WaterLOGSY peaks of the free and
bound ligand states at the three different mixing times. As
reported in Table S1, in the absence of exchangeable protons
located nearby (distance <5Å) the relative WaterLOGSY signal
intensities of the ligand protons are not modified when the mix-
ing time decreases. By contrast, for protons located near labile
protons, the mixing time has an effect, demonstrating that
exchangeable protons influence the intensities of the WaterLOGSY
peaks for protons located nearby. One example is reported in
Figure 6 for compound 3 (2,4-(1H,3H)-quinazolinedione) bound to
GP. Using 1.5 s WaterLOGSY mixing time, proton H1 is shown to
be solvent-accessible (see Figure 3(B)), displaying a weak
WaterLOGSY intensity, in agreement with the STD spectrum. At
lower mixing times, the peak intensity of proton H1 increases
(Figure 6). Therefore, using a 0.25 s WaterLOGSY mixing time, pro-
ton H1 does not appear as solvent-accessible. This is due to the
polarisation transfer with exchangeable protons, which dominates
– at low mixing time – the polarisation transfer through the pro-
tein. In conclusion, these results indicate that the structural ana-
lysis should be performed with long mixing times (close to 1.5 s)
to minimise the influence of exchangeable protons. As reported
here for the protein-ligand complexes displayed in Figures 2, 3, 4,
5 and 7, as well as the 20 protein-fragment complexes reported in
Table S1, the WaterLOGSY-based structural information is very
Figure 4. WaterLOGSY detects that fragments bind the protein target through a defined orientation and identifies solvent-exposed ligand protons: case 3 (both posi-
tive and negative WaterLOGSY peaks are observed). Compound 4 binds to HSP90 (KD¼790lM). The STD spectrum is shown in green, with the STDoff spectrum (1D)
superimposed in black. The WaterLOGSY spectrum in the absence of the protein is shown in blue, the WaterLOGSY spectrum in the presence of the protein is shown
in red. The solvent-exposed proton H1 identified using WaterLOGSY and STD experiments is labelled. The corresponding WaterLOGSY and STD factors are indicated.
The X-ray structure of the complex is shown (2XDL).
Figure 5. WaterLOGSY detects that fragments bind the protein target through a defined orientation and identifies solvent-exposed ligand protons: case 4 (all
WaterLOGSY peaks display the same sign for the bound and free compound). Compound 5 binds to the Bcl-xL protein (KD¼300lM). The STD spectrum is shown in
green, with the STDoff spectrum (1D) superimposed in black. The WaterLOGSY spectrum in the absence of the protein is shown in blue, the WaterLOGSY spectrum in
the presence of the protein is shown in red. Due to the low molecular weight of the protein, the sign of the WaterLOGSY is the same for the free and bound com-
pound (as shown in Figure 1, case 4) and therefore the two WaterLOGSY spectra are not 180 out of phase in this particular case. Therefore, in this case, the solvent-
exposed protons exhibit similar relative intensities in the presence or absence of the protein (WaterLOGSY factors is zero). The solvent-exposed proton H1 identified
using WaterLOGSY and STD experiments is labelled. The corresponding WaterLOGSY and STD factors are indicated. The peak at 7.1 ppm corresponds to one of the
imidazole resonances. The NMR structure of the complex is shown (1YSG).
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similar to the STD-based structural information, when WaterLOGSY
experiments are performed with long mixing times (1.5 s).
In the absence of exchangeable protons proximal to the pro-
tons under analysis, there is no impact of the WaterLOGSY mixing
time on the structural information, as shown for example with
compound 6 (4-phenoxybenzoic acid) bound to GP (Figure 7).
3.4. WaterLOGSY-based information compared to solvent
accessibility: quantitative analysis
The WaterLOGSY factors and the calculated solvent-accessibilities
for compounds 1, 4, and 7 are shown in Figure 8. As expected,
the protons exhibiting weaker WaterLOGSY factors correspond to
the most solvent-exposed protons in the corresponding protein-
ligand 3D structures. For weak-affinity ligands such as fragment-
like compounds, the comparison of WaterLOGSY factors between
two analogues may be used to assess the impact of a chemical
group on the binding mode of the ligand. This is illustrated in
Figure 8 for compound 1 (4-methylcatechol, see also Figure 2)
and compound 7 (4-tert-butylcatechol) bound to PRDX5.
According to the WaterLOGSY factors, the binding mode com-
pound 7 is modified in comparison to that of compound 1. This
observation is in agreement with the X-ray structure of the com-
plex of compound 7 with PRDX5, in which two binding modes
are observed (while only one binding mode was observed for
compound 1) (Figure 8). Depending on the binding modes, the
proton H1 is either buried into the protein or solvent-exposed.
The experimental WaterLOGSY factor is averaged, and no privi-
leged orientation is observed. This result shows that WaterLOGSY-
based structural information can be particularly useful to compare
the binding properties of similar compounds.
3.5. Influence of the ligand affinity
The dissociation constant for fragment binding to proteins typic-
ally ranges from low micromolar to millimolar. In the examples
reported here, the affinities are 330 mM for compound 1 bound to
PRDX527, 790 mM for compound 4 bound to HSP9032, greater than
1mM for compound 3 and 6 bound to GP (unpublished data),
Figure 6. Influence of the mixing time on the WaterLOGSY intensities for protons
positioned proximal to exchangeable protons. The WaterLOGSY spectra of com-
pound 3 bound to GP (KD >1mM) with mixing times of 1.5 s, 0.75 s, and 0.25 s
are shown in red, blue and green, respectively. The WaterLOGSY peak intensity
of proton H1 increases when the mixing time decreases.
Figure 7. The mixing time has no impact on the WaterLOGSY intensities in the
absence of proximal exchangeable protons. The WaterLOGSY spectra of com-
pound 6 bound to GP (KD >1mM) with mixing times of 1.5 s, 0.75 s, and 0.25 s
are shown in red, blue and green, respectively. The WaterLOGSY peak intensity
of proton H1 increases when the mixing time decreases. The STD spectrum is
shown in green, with the STDoff spectrum (1D) superimposed in black. The
WaterLOGSY spectra in the absence of the protein (blue), and in the presence of
the protein (red) recorded with 1.5 s mixing time are displayed. The solvent-
exposed protons H1 and H2 identified using WaterLOGSY and STD experiments
are labelled. The corresponding WaterLOGSY and STD factors are indicated.
Figure 8. WaterLOGSY factors and solvent accessibility of protons for compound 1 bound to PRDX5 (KD¼330lM), compound 7 bound to PRDX5 (KD¼50lM), and
compound 4 bound to HSP90 (KD¼790lM). The WaterLOGSY factors and the solvent accessibility calculated with Pymol are indicated for the different protons of
the compounds.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 1223
300 mM for compound 5 bound to Bcl-xL33 and 50mM for com-
pound 7 bound to PRDX527. One feature of the examples for
PRDX5 discussed here is that a weakly binding fragment (1,
330 mM) can bind with a defined orientation whereas a stronger
binding compound (7, 50 mM) binds in two alternate orientations.
These differences are seen in the X-ray crystal structures and are
reported by the WaterLOGSY signals. This suggests that this
WaterLOGSY-based method can be used to determine the binding
orientation for fragments binding with a range of affinities to a
protein target.
3.6. Assessing the epitope mapping of ligands using STD
and WaterLOGSY
For assessing the epitope mapping of ligands bound to proteins,
we strongly recommend recording both the STD and WaterLOGSY
experiments. In most cases, this can be achieved using the same
sample, even if the STD experiments require less protein quantity
than the WaterLOGSY experiments. Advantages and disadvantages
of the STD and WaterLOGSY experiments are reported in Table 1.
In case of a disagreement between STD and WaterLOGSY, we sug-
gest recording WaterLOGSY experiments at long and low mixing
times, as shown in Figure 6, to better evaluate the impact of
exchangeable ligand protons (typically when a ligand proton is
identified as solvent-exposed in STD but not in WaterLOGSY). The
opposite case, when a WaterLOGSY signal is observed while it is
not observed in an STD experiment, might indicate the presence
of a bound water molecule34. As recently reported, the presence
of water molecules in the protein-ligand complex can also be
assessed through the analysis of WaterLOGSY experiments per-
formed on deuterated protein samples26.
4. Conclusion
Our results clearly demonstrate that the comparison of
WaterLOGSY intensities for a small molecule in its free and pro-
tein-bound forms allows the identification of the ligand solvent-
exposed protons. We have reported experimental data for the
four scenarios that can be observed in the WaterLOGSY experi-
ments, together with the structural information that can be
inferred from these experiments. More importantly, we have used
six different protein targets ranging from 22 to 180 kDa to estab-
lish the large applicability of the approach. For three of the exam-
ples studied here (Bcl-xL, PRDX5, and HSP90), published
descriptions of compound optimisation confirm that these solv-
ent-exposed positions on the fragment are used in compounds
that bind with high affinity. One key point is the investigation of
the influence of ligand exchangeable protons. As shown, two
WaterLOGSY mixing times should be used to avoid mistakes in
the assessment of proton solvent accessibility.
The approach does not require any structural information for
the protein. Used alongside STD measurements, the WaterLOGSY
protocols described here provide additional confidence in the
binding mode for ligands binding to a protein. Such confidence is
important for molecular design in the absence of a complete
structure determination to guide the medicinal chemist in the
optimisation of fragments, a crucial step in fragment-based drug
discovery. The approach should be particularly valuable for cases
where a fragment binds with a defined orientation but structural
information (derived from X-ray crystallography or protein-
observed NMR spectroscopy) is not available.
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